Chemical and viral transformation of cultured skin fibroblasts from patients with familial polyposis coli.
Treatment of skin fibroblasts from an FPC patient with 4NQO or MNNG followed by sequential passaging caused morphological changes of the cells, which showed characteristics of transformed cells such as a high frequency of colony formation in agarose, increased growth ability, and chromosomal abnormalities. This and other fibroblast lines from 5 of 12 FPC patients had an increased susceptibility to 4NQO cytotoxicity, which was caused by enhanced 4NQO-reductase activity rather than by reduced DNA repair. However, the susceptibility to cytotoxicity of MNNG and repair of MNNG-damaged DNA were normal in FPC cells. The tumor promoters TPA and DHTB enhanced the frequency of chemical transformation of the FPC fibroblasts, and protease inhibitors suppressed the promoter-enhanced transformation. The skin fibroblasts from many FPC patients exhibited increased susceptibility to transformation by murine sarcoma viruses. Analysis of the viral DNA and RNA after infection revealed that the increased susceptibility is determined at an early stage of transformation. Two out of 5 MNNG-transformed clones of FPC fibroblasts, isolated from agarose, had increased expression of c-Ki-ras or c-Ha-ras, and 4 of 4 MSV-transformed clones showed high expression of viral Ki-ras. These clones grew further after isolation from agarose, but were mortal and did not form tumors in nude mice. The present results suggest that additional changes in morphologically transformed FPC fibroblasts are required for malignant transformation.
Miyaki
M
M
Department of Biochemistry, Tokyo Metropolitan Institute of Medical Science, Japan.
Akamatsu
N
N
Sato
C
C
Utsunomiya
J
J
D015112:4-Nitroquinoline-1-oxide / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D007621:Karyotyping; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology*; D008938:Mitosis; D008980:Moloney murine sarcoma virus / Q000235:genetics*; D009600:Nitroquinolines / Q000494:pharmacology*; D009053:Sarcoma Viruses, Murine / Q000235:genetics*; D012867:Skin / Q000166:cytology / Q000473:pathology*
D009600:Nitroquinolines; D008769:Methylnitronitrosoguanidine; D015112:4-Nitroquinoline-1-oxide